160 related articles for article (PubMed ID: 35032666)
1. Cellular and molecular mechanisms implicated in the dual role of ROR2 in cancer.
Castro MV; Lopez-Bergami P
Crit Rev Oncol Hematol; 2022 Feb; 170():103595. PubMed ID: 35032666
[TBL] [Abstract][Full Text] [Related]
2. ROR1 and ROR2 play distinct and opposing roles in endometrial cancer.
Henry CE; Llamosas E; Daniels B; Coopes A; Tang K; Ford CE
Gynecol Oncol; 2018 Mar; 148(3):576-584. PubMed ID: 29395309
[TBL] [Abstract][Full Text] [Related]
3. Role of the Ror family receptors in Wnt5a signaling.
Kamizaki K; Minami Y; Nishita M
In Vitro Cell Dev Biol Anim; 2024 May; 60(5):489-501. PubMed ID: 38587578
[TBL] [Abstract][Full Text] [Related]
4. Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion.
Henry C; Llamosas E; Knipprath-Meszaros A; Schoetzau A; Obermann E; Fuenfschilling M; Caduff R; Fink D; Hacker N; Ward R; Heinzelmann-Schwarz V; Ford C
Oncotarget; 2015 Nov; 6(37):40310-26. PubMed ID: 26515598
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic identification of receptor tyrosine kinase-like orphan receptor 2 as a functional tumor suppressor inhibiting β-catenin and AKT signaling but frequently methylated in common carcinomas.
Li L; Ying J; Tong X; Zhong L; Su X; Xiang T; Shu X; Rong R; Xiong L; Li H; Chan AT; Ambinder RF; Guo Y; Tao Q
Cell Mol Life Sci; 2014 Jun; 71(11):2179-92. PubMed ID: 24158497
[TBL] [Abstract][Full Text] [Related]
6. Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signalling.
Henry C; Quadir A; Hawkins NJ; Jary E; Llamosas E; Kumar D; Daniels B; Ward RL; Ford CE
J Cancer Res Clin Oncol; 2015 Feb; 141(2):243-54. PubMed ID: 25209439
[TBL] [Abstract][Full Text] [Related]
7. New insights into the molecular mechanisms of ROR1, ROR2, and PTK7 signaling from the proteomics and pharmacological modulation of ROR1 interactome.
Raivola J; Dini A; Salokas K; Karvonen H; Niininen W; Piki E; Varjosalo M; Ungureanu D
Cell Mol Life Sci; 2022 May; 79(5):276. PubMed ID: 35504983
[TBL] [Abstract][Full Text] [Related]
8. Receptor tyrosine kinase-like orphan receptor 2 (Ror2) expression creates a poised state of Wnt signaling in renal cancer.
Rasmussen NR; Wright TM; Brooks SA; Hacker KE; Debebe Z; Sendor AB; Walker MP; Major MB; Green J; Wahl GM; Rathmell WK
J Biol Chem; 2013 Sep; 288(36):26301-26310. PubMed ID: 23893409
[TBL] [Abstract][Full Text] [Related]
9. Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation.
Yu J; Chen L; Cui B; Widhopf GF; Shen Z; Wu R; Zhang L; Zhang S; Briggs SP; Kipps TJ
J Clin Invest; 2016 Feb; 126(2):585-98. PubMed ID: 26690702
[TBL] [Abstract][Full Text] [Related]
10. ROR2 promotes the epithelial-mesenchymal transition by regulating MAPK/p38 signaling pathway in breast cancer.
Xu J; Shi J; Tang W; Jiang P; Guo M; Zhang B; Ma G
J Cell Biochem; 2020 Oct; 121(10):4142-4153. PubMed ID: 32048761
[TBL] [Abstract][Full Text] [Related]
11. The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells.
Yuan Y; Niu CC; Deng G; Li ZQ; Pan J; Zhao C; Yang ZL; Si WK
Int J Mol Med; 2011 Jan; 27(1):63-9. PubMed ID: 21069266
[TBL] [Abstract][Full Text] [Related]
12. Ror2-mediated alternative Wnt signaling regulates cell fate and adhesion during mammary tumor progression.
Roarty K; Pfefferle AD; Creighton CJ; Perou CM; Rosen JM
Oncogene; 2017 Oct; 36(43):5958-5968. PubMed ID: 28650466
[TBL] [Abstract][Full Text] [Related]
13. ROR1 and ROR2 expression in pancreatic cancer.
Liu D; Sharbeen G; Phillips P; ; Ford CE
BMC Cancer; 2021 Nov; 21(1):1199. PubMed ID: 34763666
[TBL] [Abstract][Full Text] [Related]
14. The WNT/ROR Pathway in Cancer: From Signaling to Therapeutic Intervention.
Menck K; Heinrichs S; Baden C; Bleckmann A
Cells; 2021 Jan; 10(1):. PubMed ID: 33445713
[TBL] [Abstract][Full Text] [Related]
15. Stable genetic alterations of β-catenin and ROR2 regulate the Wnt pathway, affect the fate of MSCs.
Cai SX; Liu AR; He HL; Chen QH; Yang Y; Guo FM; Huang YZ; Liu L; Qiu HB
J Cell Physiol; 2014 Jun; 229(6):791-800. PubMed ID: 24590964
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia induces phenotypic plasticity and therapy resistance in melanoma via the tyrosine kinase receptors ROR1 and ROR2.
O'Connell MP; Marchbank K; Webster MR; Valiga AA; Kaur A; Vultur A; Li L; Herlyn M; Villanueva J; Liu Q; Yin X; Widura S; Nelson J; Ruiz N; Camilli TC; Indig FE; Flaherty KT; Wargo JA; Frederick DT; Cooper ZA; Nair S; Amaravadi RK; Schuchter LM; Karakousis GC; Xu W; Xu X; Weeraratna AT
Cancer Discov; 2013 Dec; 3(12):1378-93. PubMed ID: 24104062
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA ROR1-AS1 induces tumorigenesis of colorectal cancer by affecting Wnt/β-catenin signaling pathway.
Wang W; Zheng W; Zhang L; Li K
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693094
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-124 suppresses the migration and invasion of osteosarcoma cells via targeting ROR2-mediated non-canonical Wnt signaling.
Zhang C; Hu Y; Wan J; He H
Oncol Rep; 2015 Oct; 34(4):2195-201. PubMed ID: 26259653
[TBL] [Abstract][Full Text] [Related]
19. CK1ε and p120-catenin control Ror2 function in noncanonical Wnt signaling.
Curto J; Del Valle-Pérez B; Villarroel A; Fuertes G; Vinyoles M; Peña R; García de Herreros A; Duñach M
Mol Oncol; 2018 May; 12(5):611-629. PubMed ID: 29465811
[TBL] [Abstract][Full Text] [Related]
20. ROR2/Wnt5a Signaling Regulates Directional Cell Migration and Early Tumor Cell Invasion in Ovarian Cancer.
Grither WR; Baker B; Morikis VA; Ilagan MXG; Fuh KC; Longmore GD
Mol Cancer Res; 2024 May; 22(5):495-507. PubMed ID: 38334461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]